Patients with higher TBXT expression have significantly shorter progression-free survival than those with lower expression [24], and TBXT inhibits Paclitaxel-induced apoptosis in primary chordoma cell lines via carbonic anhydrase IX [25]. Here, CA9 is linked to chordoma.